Bifidobacterium bifidum 1007478 derived indole-3-lactic acid alleviates NASH via an aromatic hydrocarbon receptor-dependent pathway in zebrafish
Authors:
- 10 March 2025
- journal article
- Published by Elsevier in Life Sciences
- Vol. 369, 123557
Abstract
No abstract availableKeywords
Funding Information
- Key Technologies Research and Development Program of Anhui Province
- National Key Research and Development Program of China (2022YFA1303804)
This publication has 56 references indexed in Scilit:
- Bifidobacterium bifidum Strain BB1 Inhibits Tumor Necrosis Factor-α–Induced Increase in Intestinal Epithelial Tight Junction Permeability via Toll-Like Receptor-2/Toll-Like Receptor-6 Receptor Complex–Dependent Stimulation of Peroxisome Proliferator-Activated Receptor γ and Suppression of NF-κB p65The American Journal of Pathology, 2024
- Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathwayCell, 2024
- Lactobacillus-derived indole-3-lactic acid ameliorates colitis in cesarean-born offspring via activation of aryl hydrocarbon receptoriScience, 2023
- Indole-3-carbinol and chlorogenic acid combination modulates gut microbiome and attenuates nonalcoholic steatohepatitis in a murine modelFood Research International, 2023
- Lactobacillus plantarum-derived indole-3-lactic acid ameliorates colorectal tumorigenesis via epigenetic regulation of CD8+ T cell immunityCell Metabolism, 2023
- Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH developmentImmunity, 2022
- Lactobacillus lactis and Pediococcus pentosaceus‐driven reprogramming of gut microbiome and metabolome ameliorates the progression of non‐alcoholic fatty liver diseaseClinical and Translational Medicine, 2021
- Indole Alleviates Diet‐Induced Hepatic Steatosis and Inflammation in a Manner Involving Myeloid Cell 6‐Phosphofructo‐2‐Kinase/Fructose‐2,6‐Biphosphatase 3Hepatology, 2020
- Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis developmentJournal of Hepatology, 2019
- Fructose leads to hepatic steatosis in zebrafish that is reversed by mechanistic target of rapamycin (mTOR) inhibitionHepatology, 2014